Pennsylvania 2025-2026 Regular Session Status: In Committee 13 D cosponsors

SB 1127 — An Act amending the act of April 14, 1972 (P.L.233, No.64), known as The Controlled Substance, Drug, Device and Cosmetic Act, further providing for definitions; and providing for disposable menstrual product label requirements.

Last action — Referred to Health & Human Services

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced December 29, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Stalled 26% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 13 sponsors

    1 primary, 12 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (13 D).

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

How this bill changes current law

9 changes Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill adds definitions and labeling requirements for disposable menstrual products, including ingredient disclosure.

  • Section 2(b)

    "Disposable menstrual product" means a product used by an individual in connection with the menstrual cycle, including, but not limited to, sanitary napkins, tampons, liners and other similar products.

    Defines what constitutes a disposable menstrual product.

  • Section 2(b)

    "Fragrance allergen" means any of the following: ... Any other fragrance allergen, as determined by the Consumer Advocate, included on an authoritative list or compendium of such compounds.

    Establishes a definition for fragrance allergens.

  • Section 2(b)

    "Fragrance ingredient" means an intentionally added substance or complex mixture present in a menstrual product for which the sole purpose in the product is to impart an odor or scent or to mask odor.

    Defines fragrance ingredient related to menstrual products.

  • Section 8.1

    The following shall apply to a label of a package or box containing menstrual products manufactured for sale or distribution in this Commonwealth: ...

    Introduces new labeling requirements specifically for menstrual products.

  • Section 8.1

    (1) The manufacturer shall print the label: (i) With a plain and conspicuous list of all ingredients, which shall be listed in order of predominance.

    Requires that all ingredients of menstrual products be listed on the packaging.

  • Section 8.1

    (2) The manufacturer shall change the label on a menstrual product because of a change of an ingredient or addition of a new ingredient.

    Mandates that labels be updated when product ingredients change.

  • Section 8.1

    (c) Fragrance ingredients shall not be required to be listed on the labeling of a product except if a fragrance: (1) is a fragrance allergen; or ...

    Exempts fragrance ingredients from labeling unless they are allergens or exceed safety thresholds.

  • Section 8.1

    (d) A manufacturer of a menstrual product shall post on a publicly accessible Internet website the ingredient information required to be printed on the label as described in subsection (a).

    Requires manufacturers to provide ingredient information online.

  • Section 8.1

    (e) A person or entity that manufactures a menstrual product in violation of this section shall be fined not more than one thousand dollars ($1,000) for each violation.

    Imposes fines for non-compliance with the new labeling requirements.

Action History

  1. Referred to Health & Human Services

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 12 co-sponsors · 240 not signed on

Sponsors (1)

Co-sponsors (12)

Not signed on (240)

240 members have not signed on to this bill.

Show all 240 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

public-safety healthcare
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 1127?
SB 1127 is sponsored by Maria Collett (Democratic), Sharif Street (Democratic), Christine M. Tartaglione (Democratic), Steven J. Santarsiero (Democratic), Art Haywood (Democratic), Vincent J. Hughes (Democratic), Carolyn T. Comitta (Democratic), John I. Kane (Democratic), Jay Costa (Democratic), Amanda M. Cappelletti (Democratic), Timothy P. Kearney (Democratic), Judith L. Schwank (Democratic), and Lindsey M. Williams (Democratic).
What is the current status of SB 1127?
This bill is in committee in the Senate. Introduced December 29, 2025. It must pass committee before a floor vote.
Where can I track SB 1127?
Track SB 1127 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 1127

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 1127

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →